SUBSTITUTED MORPHOLINE COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
申请人:Warner-Lambert Company LLC
公开号:EP1745029A1
公开(公告)日:2007-01-24
US7659394B2
申请人:——
公开号:US7659394B2
公开(公告)日:2010-02-09
[EN] SUBSTITUTED MORPHOLINE COMPOUNDS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS<br/>[FR] COMPOSES DE MORPHOLINE SUBSTITUES PERMETTANT DE TRAITER DES TROUBLES DU SYSTEME NERVEUX CENTRAL
申请人:WARNER LAMBERT CO
公开号:WO2005105763A1
公开(公告)日:2005-11-10
This invention relates to compounds of the formulae (I), (II), (III), wherein R'- Re, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
Substituted morpholine compounds for the treatment of central nervous system disorders
申请人:Barta S. Nancy
公开号:US20050245519A1
公开(公告)日:2005-11-03
This invention relates to compounds of the formulae I
wherein R
1
-R
8
, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.